Europe

Dyadic Netherlands to develop enzymes for E.U.-funded research consortium

Monday, July 2, 2012 11:49 AM

Dyadic International, a global biotechnology company focused on enzymes and other proteins, announced that its R&D center in the Netherlands, a member of the multidisciplinary research consortium Bio-Mimetic Project, has been awarded a $4.4 million grant from the European Community's Seventh Framework Programme (FP7) of the European Community for Research, Technological Development and Demonstration Activities.

More... »

Theradiag acquires Prestizia and microRNA technology platform

Monday, July 2, 2012 11:31 AM

Theradiag, a French theranostics and in vitro diagnostics company focused on autoimmune disease, has decided to acquire Prestizia, a French biotechnology company that develops microRNA technology.

More... »

BioInvent reorganizes after TB-402 bust

Friday, June 29, 2012 12:53 PM

BioInvent International, a Swedish research-based pharmaceutical company that focuses on developing antibody drugs, has decided to initiate negotiations with trade unions regarding organizational changes due to halting development of the antithrombotic agent TB‑402.

More... »

Shire’s VPRIV shows significant improvement in Gaucher-related bone disease

Friday, June 29, 2012 12:38 PM

Shire, a global specialty biopharmaceutical company based in Dublin, released new data that show VPRIV (velaglucerase alfa for injection), the company’s enzyme replacement therapy for type 1 Gaucher disease, significantly improved selected markers of Gaucher-related bone disease in patients.

More... »

Quintiles to offer jobs to 100 Merck Serono employees affected by cuts

Wednesday, June 27, 2012 10:16 AM

CRO Quintiles has committed to make at least 100 employment offers within the next three months to Merck Serono employees primarily working in global development and medical function in Geneva.

More... »

Accovion GmbH expands global presence in Spain

Monday, June 25, 2012 10:31 AM

Accovion GmbH, a full-service provider of clinical development services based in Eschborn, Germany, has launched an additional subsidiary in Spain.

More... »

DSM inks major commercial agreement for its XD technology

Wednesday, June 20, 2012 11:55 AM

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, has signed a commercial agreement for contract manufacturing services using its proprietary XD high cell density process technology with a major pharma company.

More... »

Merck Serono announces final efficiency program for Switzerland

Wednesday, June 20, 2012 10:03 AM

After a long consultation process, Merck Serono, the biopharmaceutical division of Merck, had made its final plan for restructuring its operations in Switzerland, closing its Geneva and Coinsins sites.

More... »

Trophos appoints Christine Placet as CEO

Monday, June 18, 2012 12:22 PM

Trophos, a French clinical stage pharmaceutical company developing therapeutics for under-served needs in neurology and cardiology, has appointed Christine Placet as chief executive officer.

More... »

Trial Masters and Zeincro merge to create specialist CRO in South-Eastern Europe

Thursday, June 14, 2012 10:00 AM

Zeincro, a specialist provider of clinical research services in Greece, Turkey and Cyprus, is merging with Trial Masters, a CRO managing clinical trials in Hungary and Romania.

More... »